Novelion Therapeutics (NVLN) was quite active in trading today. The stock has been mostly bullish since Thursday morning after the company confirmed that it had secured funding to continue its operations into 2019. The company has products already approved by the FDA and has six other products in development either at phase 2 or phase 3 status. However, NVLN has a relatively high amount of debt and thus news of its securing funding set the stock into motion. Here’s a recap of what’s happened to NVLN over the last two days.
Novelion Therapeutics Finds A Backer
Read Similar Articles
Q1 Earnings Season Preview: What To Expect
As we start a brand new quarter in 2026, it also resets the earnings cycle for companies to report their quarterly results — and I believe that Q1 Earnings Season could have a lot in store. Q4 earnings season at the start of the year gave traders a lot to process. It also set the […]
Read ArticleMarch 2026 Jobs Report: The Good, Bad, & Unexpected
The March 2026 Jobs Report was among the most anticipated ones in recent memory. Right now, the economy is being shaped by a number of factors: These current circumstances — combined with February’s bad jobs report — had traders preparing for the worst. Fortunately, the March 2026 Jobs Report looked much better than expected…at least […]
Read ArticleCould Penny Stocks Be The Big Play In 2026?
Written By: Howard Greenberg As everyday traders put their trading plans into action for 2026, penny stocks might not be on many of their radars. It’s totally understandable why penny stocks may not appeal to the more calculated seasoned traders. Their reputations for susceptibility to manipulation, extreme volatility, and low liquidity make them way too […]
Read ArticleRead Similar Articles
The Big Move Scott Calculated In Amazon Stock
Amazon stock has had a wild year. It’s up over 15% in 2026 — and nearly 31% in the last month! It’s one of five Mag 7 stocks that report earnings this week, and among four that reveal their quarterly results on Wednesday, April 29. Scott Bauer loves Amazon stock, and has it on his […]
Read ArticleWeekly Earnings Prep: 3 Things To Know For Earnings This Week
We’re entering a big week this earnings season, with some of the MAG7 names like MSFT, GOOGL, META, AMZN, and AAPL all reporting. Over the next few Sundays, you’ll be hearing from 2-3 of the Prosper coaches, who will share one stock with upcoming earnings that’s on their radar. You’ll learn why they’re watching each […]
Read ArticleThe Week Ahead: News Overload
It’s great to be back. I had an amazing time visiting my son in Spain and now it’s time to dig back in. Equity markets continue to price in optimism that the Iran conflict may be nearing an end, even as it stretches past eleven weeks and Strait of Hormuz traffic remains at a standstill. […]
Read Article





